# OnCo record hebrew-university-of-jerusalem (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/hebrew-university-of-jerusalem/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "hebrew-university-of-jerusalem" ;
  schema:name "Hebrew University of Jerusalem"@en ;
  schema:alternateName "HUJI"@en, "Hebrew University"@en, "Hebrew University-Hadassah Medical School"@en, "Yissum"@en ;
  schema:description "Jerusalem's research university, whose Hadassah medical school produced Doxil, the first nanomedicine any regulator approved, and whose technology transfer company Yissum licensed it."@en ;
  schema:url <https://onco.cc/institutions/hebrew-university-of-jerusalem/>, <https://en.huji.ac.il> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hebrew_University_of_Jerusalem> ;
  schema:citation <https://en.huji.ac.il>, <https://doi.org/10.1016/j.jconrel.2012.03.020>, <https://www.yissum.co.il> ;
  schema:addressCountry "IL" ;
  schema:addressLocality "Jerusalem" ;
  schema:latitude "31.794"^^xsd:decimal ;
  schema:longitude "35.243"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/kaposi-sarcoma/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:drugs <https://onco.cc/drugs/pegylated-liposomal-doxorubicin/> ;
  onco:institutions <https://onco.cc/institutions/hadassah/>, <https://onco.cc/institutions/shaare-zedek/> ;
  onco:people <https://onco.cc/people/yechezkel-barenholz/> .